The US Food and Drug Administration has published a final order allowing sponsors to use the 510(k) pathways for photoplethysmograph analysis software used to detect irregular heart rhythm. The decision comes two years after the agency authorized Apple’s photoplethysmograph analysis app on its Apple Watch.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?